Literature DB >> 4146358

Treating problem children with stimulant drugs.

L A Sroufe, M A Stewart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4146358     DOI: 10.1056/NEJM197308232890806

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Editorial: Hyperactivity in children.

Authors: 
Journal:  Br Med J       Date:  1975-10-18

2.  Self-medication with mood changing drugs.

Authors:  D G Grahame-Smith
Journal:  J Med Ethics       Date:  1975-09       Impact factor: 2.903

3.  Medication for hyperkinetic children.

Authors:  J S Werry
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Group counseling for parents of hyperactive children.

Authors:  J W Schaefer; H S Palkes; M A Stewart
Journal:  Child Psychiatry Hum Dev       Date:  1974

5.  Formal and informal classroom settings: effects on hyperactivity.

Authors:  R G Jacob; K D O'Leary; C Rosenblad
Journal:  J Abnorm Child Psychol       Date:  1978-03

6.  Relative efficacy of methylphenidate and behavior modification in hyperkinetic children: an interim report.

Authors:  R Gittelman-Klein; D F Klein; H Abikoff; S Katz; A C Gloisten; W Kates
Journal:  J Abnorm Child Psychol       Date:  1976

7.  Equivocal neurological signs, child development, and learned behavior.

Authors:  R M Foster; L Margolin
Journal:  Child Psychiatry Hum Dev       Date:  1978

8.  Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children.

Authors:  R Tannock; R Schachar; G Logan
Journal:  J Abnorm Child Psychol       Date:  1995-04

9.  Individual responses to methylphenidate and caffeine in children with minimal brain dysfunction.

Authors:  B D Garfinkel; C D Webster; L Sloman
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

10.  Experimentation with human subjects: a critique of the views of Hans Jonas.

Authors:  A Schafer
Journal:  J Med Ethics       Date:  1983-06       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.